C4 Therapeutics, Inc. 10-Q filing
Filed 2026-05-12 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-033865
- Form type
- 10-Q
- CIK
- 0001662579
- Primary document
- https://www.sec.gov/Archives/edgar/data/1662579/000162828026033865/cccc-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for C4 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $6.2M | - | - |
| Operating Income | $-27.8M | - | - |
| Net Income | $-25.1M | - | - |
| Eps Basic | -0.2 | - | - |
| Eps Diluted | -0.2 | - | - |
| Cash And Equivalents | $61.3M | - | - |
| Total Assets | $328.9M | - | - |
| Total Liabilities | $94.6M | - | - |
| Shareholders Equity | $234.2M | - | - |
| Operating Cash Flow | $-29.9M | - | - |
| Capital Expenditures | $64,000 | - | - |